RecruitingNCT07562191

Inhaled DMT for depression

Researchers are evaluating the effects and safety of different inhaled DMT doses in adults with depression.

Inhaled medicationAges 18+Brazil

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Fortaleza and 4 more locationsSee all locations and recruitment
Study phase: Phase 2

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateEstimated: August 1, 2026

Recruitment status: Recruiting
Enrollment listed in the registry: 140
Sponsor: Universidade Federal do Rio Grande do Norte
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: Brazil
Age range: Over 18 Years
Official registry ID: NCT07562191
Official title: Show the full official title
Randomized, Double-Blind, Placebo-Controlled Phase IIb Trial of Inhaled N,N-Dimethyltryptamine (DMT) for Major Depressive Disorder

Currently recruiting

Fortaleza · Salvador · Rio de Janeiro

2 more locations

FAQ

Who is behind this study?

The study sponsor is Universidade Federal do Rio Grande do Norte.

Does this study involve medication?

Yes. The study involves medication, including N,N-Dimethyltryptamine (15 mg + 60 mg) and N,N-Dimethyltryptamine (1 mg + 4 mg).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.